Pharmafile Logo
Pharmafocus logo
Advanced Search
fda

FDA approves opioid Olinvyk for patients with acute pain

August 10, 2020
Sales and Marketing opioid crisis, opioids

The FDA has approved Olinvyk for the management of moderate to severe pain in adult patients when their pain is …

News
fdaoutsideweb

Genentech’s Evrysdi becomes first FDA-approved oral treatment for spinal muscular atrophy

August 10, 2020
Sales and Marketing Evrysdi, FDA, Genentech, Roche, spinal muscular atrophy

Genentech’s Evrysdi (risdiplam) has secured FDA approval for the treatment of spinal muscular atrophy (SMA), making it the first oral therapy …

News
vaccination-1215279_960_720

Early promise from Novavax’s vaccine candidate for COVID-19

August 7, 2020
Medical Communications, Research and Development COVID-19, Novavax, Vaccine

New Phase 1/2 on Novavax’s COVID-19 vaccine candidate NVX‑CoV2373 has shown that the therapy generated “robust antibody responses” when used …

News
covid_innovations_bamc

Researchers at the University of Oxford have said hydroxychloroquine could still be a viable COVID-19 treatment

August 7, 2020
Medical Communications COVID, hydroxychloroquine

Researchers at the University of Oxford have said that hydroxychloroquine could be beneficial to COVID-19 patients, despite a general lack …

News
astrazeneca_building_white

AstraZeneca seals manufacturing deal to deliver COVID-19 vaccine in China

August 7, 2020
Manufacturing and Production, Medical Communications AstraZeneca, COVID-19, China, pharma

AstraZeneca has signed its first deal in China to produce and deliver its vaccine candidate against COVID-19 in the country, …

News
50185852257_94002eda8f_b

Trump signs executive order to direct federal agencies to prioritise purchasing drugs made in the US

August 7, 2020
Manufacturing and Production, Medical Communications, Sales and Marketing FDA, Peter Navarro, Trump, drug prices

US President Donald Trump has signed an executive order which will direct federal agencies to prioritise buying drugs and drug …

News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

August 7, 2020
Medical Communications COVID-19, Top 10 news, top 10

The top ten news stories this week are dominated by corporate scandals, with researchers finding that Coca-Cola paid an organisation …

News
astrazeneca_plaque

AstraZeneca’s Fasenra has strong Phase 3 showing in severe eosinophilic asthma

August 6, 2020
Research and Development AstraZeneca, Fasenra, asthma

AstraZeneca took the opportunity at the American Thoracic Society 2020 Virtual International Conference to unveil positive new Phase 3b data …

News
novartis_side_building

Novartis’ Xolair scores European approval to treat chronic rhinosinusitis with nasal polyps

August 6, 2020
Sales and Marketing Novartis, Xolair, rhinosinusitis

Novartis has snapped up approval from the European Commission for its anti-immunoglobulin E (IgE) antibody therapy Xolair (omalizumab) for the …

News
800px-european_commission_flags

European Commission approves first drug for hepatitis D

August 6, 2020
Business Services EC, hepatitis C, hepatitis D

The European Commission has approved Heplcudex (bulvirtide) as the first hepatitis D drug. It was jointly developed by researchers at …

News
j_and_j

US to pay Johnson and Johnson $1 billion for COVID-19 vaccine

August 6, 2020
Business Services COVID-19, J&J, JJ, Johnson and Johnson, coronavirus

The US will pay Johnson and Johnson more than $1 billion to create 100 million doses of COVID-19 vaccine. The …

News
800px-kodak_colorplus_200_135_film_cartridge_and_box

US Democrats probe Trump administration’s $765 million loan to Kodak to produce drug ingredients

August 6, 2020
Business Services

Democratic members of Congress are set to investigate the Trump administration’s $765 million federal loan awarded to Kodak as it …

News
morris

Humanigen appoints Timothy Morris as Chief Operating Officer and Chief Financial Officer

August 5, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Humanigen have appointed Timothy E. Morris to its newly created role of Chief Operating Officer and Chief Financial Officer and …

Appointment
nice_new_london_office_internal_3_web

NICE rejects mycosis fungoides-type cutaneous T-cell lymphoma therapy over data concerns

August 5, 2020
Research and Development, Sales and Marketing Ledaga, NICE, lymphoma

NICE has announced its rejection of Ledaga (chlormethine gel), a topical therapy for the treatment of mycosis fungoides-type cutaneous T-cell …

News
800px-nhs_nnuh_entrance

NICE advises GPs to stop prescribing opioids for chronic pain

August 5, 2020
Business Services, Research and Development COVID-19, coronavirus

The National Institutes of Health and Care Excellence has released its first guideline on the treatment of chronic pain and …

News

EMA expands label for UCB’s Cimzia in axial spondyloarthritis

August 5, 2020
Research and Development, Sales and Marketing Cimzia, EMA, Europe

The European Medicines Agency has expanded the existing approval of UCB’s Cimzia (certolizumab pegol) to cover the treatment of axial …

News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

August 5, 2020
Research and Development COVID-19, Weekly round up, coronavirus

The coronavirus news this week is dominated by vaccine development, as the UK Government sealed another deal to procure an …

News
coca-cola_bottles_for_thai_market_1

Researchers find Coca-Cola paid scientists to downplay how their drinks fuelled the obesity crisis

August 5, 2020
Research and Development, Sales and Marketing Coca-Cola, Coke

Researchers have found that Coca-Cola paid an organization of scientists to downplay how the sugary drinks they sell fuelled the …

News
chrissy

Medipharma appoints Former President of Janssen Chris Halyk to its Board of Directors

August 4, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Medipharma has appointed Chris Halyk, the former President of Janssen, to its Board of Directors. This is the third appointment …

Appointment
enoch_kariuki

VelosBio reveals new Chief Financial Officer

August 4, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing VelosBio, appointment

Dr Enoch Kariuki has been named as the new Chief Financial Officer at biopharma firm VelosBio, where he will assume …

Appointment
The Gateway to Local Adoption Series

Latest content

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026

European Medicines Agency recommended 104 medicines for approval in 2025

January 20, 2026